Prohost Biotech - Exclusive Biotech Research - A Comprehensive Resource for Biotech News

Moderna COVID-19 Vaccine Produced Neutralizing Titers Against Key Emerging Variants Tested

January 28, 2021 0

Moderna COVID-19 Vaccination News A vaccination with the Moderna (MRNA) COVID-19 produced neutralizing titers against all …

CASI Partner, BioInvent, Announced the Combination of Rituximab with BI-1206 restored riruximab’s Capability to Treat Indolent Relapsed or Refractory B-cell non-Hodgkin’s Lymphoma

January 28, 2021 0

CASI Pharmaceuticals Partner, BioInvent International, Announced Positive Interim Results for NHL CASI Pharmaceuticals (CASI) partner BioInvent …

Aurinia Pharmaceuticals: FDA Approved LUPKYNIS for Active Lupus Nephritis in Adults

January 27, 2021 0

Aurinia Pharmaceuticals LUPKYNIS Approved for LN in Adults Aurinia Pharmaceuticals (AUPH) has been granted a U.S. …

Merck Has Interesting News and Impressive Results

January 26, 2021 0

Merck Discontinues Development of COVID-19 Vaccine Candidates Merck (MRK) known as MSD outside the United States and …

ViiV Healthcare: The FDA Approved Cabenuva for Adults Who are HIV Virologically-Suppressed

January 25, 2021 0

ViiV Healthcare Announced FDA Approval for Cabenuva for Adults with HIV-1 From London we learned that …

Exelixis: The FDA Approved Cabometyx in Combination with Opdivo as a First Line Treatment of RCC

January 23, 2021 0

Exelixis: FDA Approval for Cabometyx in Combination with Opdivo Exelixis (EXEL) announced that the United States FDA …

Compugen: Why the Great Expectations from this Firm

January 22, 2021 0

The Compugen Story For those who are still asking about the value of Compugen’s (CGEN) discoveries …

Sutro Biopharma Dosed the First Patient in the Dose-Expansion Cohort of the Phase 1 STRO-002 Study

January 21, 2021 0

Sutro Biopharma Therapeutic Discovery and Technology Sutro Biopharma (STRO) uses precise protein engineering and rational design …

News About Reata Pharmaceuticals

January 19, 2021 0

Reata Pharmaceuticals The Positive News Prohost Biotech's interest in Reata Pharmaceuticals (RETA) started when we recognized …

bluebird bio: The Appealing Decision to Separate its Severe Genetic Disease and Oncology Businesses into Independent Publicly-Traded Firms

January 14, 2021 0

bluebird bio Decision to Separate its Businesses bluebird bio (BLUE) will retain focus on its severe genetic …

La Jolla Pharmaceutical Company Announced an Exclusive Licensing Agreement for GIAPREZA and XERAVA in Europe

January 12, 2021 0

La Jolla Pharmaceutical Company Announced an Exclusive Licensing Agreement for GIAPREZA and XERAVA La Jolla Pharmaceutical …

Underlining Exelixis Bright Future

January 11, 2021 0

Exelixis Bright Future Exelixis Fourth Quarter and Full Year 2020 Financial Results Exelixis (EXEL) announced …

For Those Still Asking Why the CRiSPR Gene Editing Stocks are Soaring

January 7, 2021 0

Intellia Therapeutics and CRISPR/Cas9 Technology Intellia Therapeutics (NTLA) is a genome editing company, focused on the …

Rhythm Pharmaceuticals: Successful Results from Phase 3 Trial with Setmelanotide for Obesity Caused by Genetic BBS

December 29, 2020 0

Rhythm Pharmaceuticals Announces Successful Phase 3 Trial Results for Obesity In November 2020, when the U.S. …

Inovio: Exciting News Published in The Lancet

December 24, 2020 0

Inovio Phase 1 Data of INO-4800 for COVID-19 Peer-reviewed Phase 1 data shows Inovio COVID-19 DNA …

Regenxbio: Advancing its Gene Therapy Pipeline and its Rare Neurodegenerative Disease Platform with Non-Dilutive Capital

December 23, 2020 0

Regenxbio Regenxbio (RGNX) announced that it is selling a portion of its royalty rights from the …

Compugen: More Highlighted News

December 23, 2020 0

Compugen Exclusive License Agreement with AstraZeneca In April 2018 Compugen (CGEN) and AstraZeneca (AZN) entered into …

Gilead Sciences has Good News for Relapsed or Refractory Mantle Cell Lymphoma and More

December 16, 2020 0

Gilead Sciences Company, Kite Pharma, News Kite Pharma, a Gilead Company (GILD), announced that the European Commission …

Intellia Therapeutics: Reinforcing the Promise of Potentially Curing Diseases

December 15, 2020 0

Intellia Therapeutics in the News Intellia Therapeutics (NTLA) presented the first demonstration of physiological protein levels …

Acquisitions that Make Sense

December 14, 2020 0

Acquisitions AstraZeneca Acquires Alexion Pharmaceuticals AstraZeneca (AZN) and Alexion Pharmaceuticals (ALXN) entered into a definitive agreement for …

Exclusive Market Insight

& Scientific analysis

Latest Articlesddd